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The global and regional burden of stroke
Stroke is the second leading cause of death and the third 
leading cause of disability-adjusted life-years (DALYs) 
worldwide.1,2 Moreover, the global burden of stroke is 
increasing. Between 1990 and 2010, the number of 
stroke-related deaths increased by 26% and DALYs by 
19%.1,2 Is this epidemic of stroke global or regional, and 
what is the explanation?
A systematic review3 of 56 population-based studies 
of the incidence and early case fatality of stroke, 
published from 1970 to 2008, showed that, in ten 
low-income and middle-income countries, the age-
adjusted incidence of stroke more than doubled, from 
52 per 100 000 person-years in 1970–79 to 117 per 
100 000 person years in 2000–08—an increase of 5·6% 
per year. However, the incidence of stroke in 18 high-
income countries almost halved, from 163 to 94 per 
100 000 person-years—a decrease of 1% per year.3 These 
data suggest divergent patterns of stroke epidemiology 
in diﬀ erent socioeconomic regions of the world, but 
might be subject to selection or sampling bias because 
of sampling of only ten of the world’s low-income 
and middle-income countries over four decades, and 
diagnostic or stroke classiﬁ cation bias because of a 
failure to distinguish major pathological subtypes of 
stroke (ie, ischaemic vs haemorrhagic), which have 
diﬀ erent diagnostic criteria, causes, and outcomes.
In The Lancet Global Health, Rita Krishnamurthi and 
colleagues from the Global Burden of Diseases, Injuries, 
and Risk Factors Study 2010 (GBD 2010) and Stroke 
Expert Group estimate the incidence, mortality, and 
DALYs of ﬁ rst-ever ischaemic and haemorrhagic stroke 
(intracerebral and subarachnoid haemorrhage) in all 
21 regions of the world in 1990, 2005, and 2010.4 The 
investigators derived the estimates from a systematic 
review of all relevant studies published between 
1990 and 2010. 119 studies were identiﬁ ed in which 
pathological subtypes of stroke were conﬁ rmed by 
brain imaging or autopsy in at least 70% of cases. 
Speciﬁ c analytical techniques were used to calculate 
regional and country-speciﬁ c estimates of incidence 
and mortality rates and DALYs lost, by age group and 
country income status.
Surprisingly, the major ﬁ nding is that, in 2010, most 
of the global burden of stroke was due to haemorrhagic, 
not ischaemic, stroke. Haemorrhagic stroke constituted 
a third (31·5%) of the 16·9 million incident stroke 
events (20% in the high-income countries and 37% 
in the low-income and middle- income countries), 
which is higher than hitherto appreciated.4 However, 
despite being only half as common as ischaemic stroke, 
haemorrhagic stroke caused more than half (51·7%) of 
the 5·9 million stroke-related deaths, and three ﬁ fths 
(61·5%) of the 102·2 million DALYs lost throughout 
the world. The number of years of life lost were greater 
with haemorrhagic stroke because it aﬀ ected people 
at a younger age (mean 65·1 years [SD 0·11]) than did 
ischaemic stroke (73·1 years [0·10]) and had a higher 
case fatality (57% vs 25%).
The second major ﬁ nding is that most of the burden 
of ischaemic and haemorrhagic stroke is in low-income 
and middle-income countries, which bear 63% of 
incident ischaemic strokes and 80% of haemorrhagic 
strokes, 57% of deaths due to ischaemic stroke and 84% 
due to haemorrhagic stroke, and 64% of DALYs lost 
due to ischaemic stroke and 86% due to haemorrhagic 
stroke. The average age of incident and fatal ischaemic 
and haemorrhagic strokes was 6 years younger in low-
income and middle-income countries than in high-
income countries. 
The third ﬁ nding is that most of the burden of 
ischaemic and haemorrhagic stroke is in people younger 
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Prevalence Odds ratio
(99% CI)
Population-
attributable risk
Controls Cases
History of hypertension 954/2996
(32%)
399/662
(60%)
3·8 (3·0–4·8) 44% (37–52%)
Regular physical activity 362/2994
(12%)
45/662
(7%)
0·7 (0·4–1·1) 28% (7–67%)
Waist-to-hip ratio (T3 vs T1) 984/2960
(33%)
231/655
(35%)
1·4 (1·02–1·9) 26% (14–43%) 
Diet risk score (T3 vs T1) 904/2982
(30%)
221/658
(34%)
1·4 (1·01–2·0) 24% (12–43%)
Alcohol intake* 324/2989
(11%)
108/660
(16%)
2·0 (1·3–3·0) 15% (8–24%)
Current smokers 732/2994
(24%)
207/662
(31%)
1·4 (1·1–2·0) 9% (4–20%)
Psychosocial stress 440/2987
(15%)
124/654
(19%)
1·2 (0·9–1·7) 3% (1–16%)
Data are n/N (%), unless otherwise indicated. Multivariable model adjusted for age, sex and region. *More than 
30 drinks per month or binge drinker. T3=tertile 3. T1=tertile 1.
Table: Risk factors for haemorrhagic stroke in 663 cases of acute ﬁ rst haemorrhagic stroke (within 5 days 
of symptom onset) compared with 3000 controls with no history of stroke who were matched with 
cases for age and sex, assessed in 22 countries between 2007 and 20106
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than 75 years, who bear 62% of incident ischaemic 
strokes and 78% of haemorrhagic strokes, and 63% 
of DALYs lost due to ischaemic stroke and 83% due to 
haemorrhagic stroke. 
The fourth ﬁ nding is that, over the past two decades 
(1990–2010) the absolute number of people with 
incident ischaemic stroke has increased signiﬁ cantly 
by 37% and incident haemorrhagic stroke by 47%, the 
number of deaths due to ischaemic stroke by 21% and 
haemorrhagic stroke by 20%, and the number of DALYs 
lost due to ischaemic stroke by 18% and haemorrhagic 
stroke by 14%. The increase in absolute numbers has 
arisen despite a reduction in the age-standardised 
incidence of ischaemic stroke by 13% and haemorrhagic 
stroke by 19%, a reduction in the mortality rates of 
ischaemic stroke by 37% and haemorrhagic stroke 
by 38%, and a reduction in DALYs rates of ischaemic 
stroke by 34% and haemorrhagic stroke by 39%. The 
reduction in rates probably shows improved education, 
prevention, diagnosis, treatment, and rehabilitation 
of stroke. The increase in absolute numbers, despite 
a reduction in rates, is presumably because global 
population growth and increasing life expectancy have 
increased the denominator by a greater proportion than 
the increasing number of stroke events has increased 
the numerator.
The ﬁ fth ﬁ nding is that the incidence of haemorrhagic 
stroke in low-income and middle-income countries is 
one rate that has increased over the past two decades 
(22% increase, 95% CI 5–30), particularly in people 
younger than 75 years (19%, 5–30). Indeed, low-
income and middle-income countries had a 40% higher 
incidence, 77% higher mortality, and 65% higher DALY 
rates of haemorrhagic stroke than did high-income 
countries. 
Krishnamurthi and colleagues’ results suggest that key 
priorities in the quest to reduce the global and regional 
burden of stroke are prevention of haemorrhagic stroke, 
particularly in low-income and middle-income countries, 
and in people younger than 75 years. Most haemorrhagic 
strokes can be attributed to hypertension and an 
unhealthy lifestyle (eg, physical inactivity, obesity, 
unhealthy diet, alcohol excess, and smoking; table).5,6
Population-based mass strategies to reduce 
consumption of salt, calories, alcohol, and tobacco 
by improving education and the environment will 
complement high-risk strategies of identifying those 
at risk of haemorrhagic (and ischaemic) stroke, thus 
empowering these individuals to improve their lifestyle 
behaviours and, if necessary, lower their mean blood 
pressure and blood pressure variability with appropriate 
doses of antihypertensive drugs.7–10
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